CCCC NASDAQ
C4 Therapeutics, Inc.
1W: -1.0%
1M: -22.2%
3M: -28.7%
YTD: +52.9%
1Y: +37.2%
3Y: +63.0%
5Y: -94.0%
$2.95
-0.19 (-6.05%)
Weekly Expected Move ±7.7%
$2
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — CCCC
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (21)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 52.0 | 64.7 | 58.3 | 58.3 | SEC ↗ |
| 2026-03-31 | 10-Q | 51.4 | 65.0 | 58.0 | 58.1 | SEC ↗ |
| 2025-12-31 | 10-K | 53.8 | 66.1 | 60.7 | 60.2 | SEC ↗ |
| 2025-09-30 | 10-Q | 51.3 | 64.6 | 56.3 | 57.4 | SEC ↗ |
| 2025-06-30 | 10-Q | 51.2 | 64.1 | 56.4 | 57.2 | SEC ↗ |
| 2024-12-31 | 10-K | 51.8 | 65.8 | 60.5 | 59.4 | SEC ↗ |
| 2024-09-30 | 10-Q | 50.2 | 64.7 | 56.4 | 57.1 | SEC ↗ |
| 2024-06-30 | 10-Q | 50.3 | 64.9 | 56.9 | 57.3 | SEC ↗ |
| 2023-12-31 | 10-K | 54.2 | 65.9 | 60.5 | 60.2 | SEC ↗ |
| 2023-06-30 | 10-Q | 54.2 | 64.3 | 59.6 | 59.4 | SEC ↗ |
| 2023-03-31 | 10-Q | 54.1 | 63.2 | 59.4 | 58.9 | SEC ↗ |
| 2022-12-31 | 10-K | 53.2 | 64.5 | 62.2 | 60.0 | SEC ↗ |
| 2022-09-30 | 10-Q | 54.1 | 62.2 | 58.3 | 58.2 | SEC ↗ |
| 2022-06-30 | 10-Q | 54.8 | 63.0 | 59.7 | 59.2 | SEC ↗ |
| 2022-03-31 | 10-Q | 54.1 | 61.7 | 57.6 | 57.8 | SEC ↗ |
| 2021-12-31 | 10-K | 53.4 | 62.1 | 59.8 | 58.4 | SEC ↗ |
| 2021-09-30 | 10-Q | 52.4 | 61.6 | 58.5 | 57.5 | SEC ↗ |
| 2021-06-30 | 10-Q | 52.5 | 61.4 | 58.5 | 57.5 | SEC ↗ |
| 2021-03-31 | 10-Q | 52.3 | 59.5 | 56.0 | 55.9 | SEC ↗ |
| 2020-12-31 | 10-K | 51.5 | 61.5 | 60.7 | 57.9 | SEC ↗ |
| 2020-09-30 | 10-Q | 52.9 | 59.4 | 57.1 | 56.4 | SEC ↗ |